Mothers against decapentaplegic homolog 6
| It has been suggested that this article or section be merged into Mothers against decapentaplegic. (Discuss) |
| The introduction to this November 2006 provides insufficient context for those unfamiliar with the subject. Please help improve the article with a good introductory style. |
| SMAD, Mothers against decapentaplegic homolog 6 | |
|---|---|
| Other names: | SMAD 6, Mothers against DPP homolog 6, Smad6, hSMAD6 |
| Genetic data | |
| Gene code: | HUGO code:SMAD6 |
| Protein Structure/Function | |
| Protein type: | I-SMAD (Inhibitory SMAD) |
| Functions: | signal transduction, transcription |
| Domains: | MH1, MH2 |
| Other | |
| Taxa expressing: | Homo sapiens; homologs: many metazoan phyla |
| Cell types: | ubiquitous; high levels in lungs |
| Subcellular localization: | Primary:nucleus, Alternative:cytoplasm |
| Covalent modifications: | phosphorylation |
SMAD6 or mothers against decapentaplegic homolog 6 is a polypeptide that, as its name describes, is a homolog of the Drosophila gene "mothers against decapentaplegic". It belongs to the SMAD family of proteins, which belong to the TGFβ superfamily of modulators. Like many other TGFβ family members SMAD6 is involved in cell signalling. It acts as a regulator of TGFβ family (such as bone morphogenetic proteins) activity by competing with SMAD4 and preventing the transcription of SMAD4's gene products. There are two known isoforms of this protein.
| '
| |
| Identifiers | |
| Symbol | SMAD6 |
| Alt. Symbols | MADH6 |
| Entrez | 4091 |
| HUGO | 6772 |
| OMIM | 602931 |
| RefSeq | NM_005585 |
| UniProt | O43541 |
| Other data | |
| Locus | Chr. 15 q21-q22 |
Nomenclature
The SMAD proteins are homologs of both the drosophila protein, mothers against decapentaplegic (MAD) and the C. elegans protein SMA. The name is a combination of the two. During Drosophila research, it was found that a mutation in the gene, MAD, in the mother, repressed the gene, decapentaplegic, in the embryo. The phrase "Mothers against" was added since mothers often form organizations opposing various issues eg. Mothers Against Drunk Driving or (MADD).
Cell signaling: TGF beta signaling pathway | |
|---|---|
| TGF beta superfamily of ligands | TGF beta family (TGF-β1, TGF-β2, TGF-β3) Bone morphogenetic proteins (BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8a, BMP8b, BMP10 , BMP15) Growth differentiation factors (GDF1, GDF2, GDF3, GDF5, GDF6, GDF7, Myostatin/GDF8, GDF9, GDF10, GDF11, GDF15) Other (Activin A and B/Inhibin A and B, Anti-müllerian hormone, Nodal) |
| TGF beta receptors | TGFBR1: Activin type 1 receptors (ACVR1, ACVR1B, ACVR1C) - ACVRL1 - BMPR1 (BMPR1A - BMPR1B) TGFBR2: Activin type 2 receptors (ACVR2A, ACVR2B) - AMHR2 - BMPR2 TGFBR3: betaglycan |
| Transducers/SMAD | R-SMAD (SMAD1, SMAD2, SMAD3, SMAD5, SMAD9) - I-SMAD (SMAD6, SMAD7) - SMAD4 |
| Ligand Inhibitors | Cerberus - Chordin - DAN - Decorin - Follistatin - Gremlin - Lefty - LTBP1 - Noggin - THBS1 |
| Coreceptors | BAMBI - Cripto |
| Other | SARA |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies